← Open Payments lookup

DAMARIS IRIONDO: Open Payments

NPI 1821756982 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$520 in 24 payments from 15 companies in 2025. Trend: 2023 $4,749 · 2024 $731 · 2025 $520

Food & beverage: $520
CompanyPaymentsAmount
SUN PHARMACEUTICAL INDUSTRIES INC.5$110
GENZYME CORPORATION2$60
Journey Medical Corporation2$43
Galderma Laboratories, L.P.2$43
Ortho Dermatologics, a division of Bausch Health US, LLC2$38
ABBVIE INC.2$37
MAYNE PHARMA COMMERCIAL LLC1$29
Novartis Pharmaceuticals Corporation1$25
Medimetriks Pharmaceuticals, Inc.1$24
Solta Medical, a division of Bausch Health US, LLC1$23

Products named: Winlevi, DUPIXENT, ILUMYA, NEMLUVIO, Cabtreo, Rhapsido, Neo-Synalar, Fraxel.

Industry payments across TX — which companies pay providers there.